83 related articles for article (PubMed ID: 7738664)
21. 131I-metaiodobenzylguanidine--a new agent for scintigraphic imaging and treatment of pheochromocytoma.
Fischer M; Vetter W; Winterberg B; Vetter H
Nuklearmedizin; 1984 Apr; 23(2):77-9. PubMed ID: 6473116
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of iodine-123 MIBG uptake by normal adrenal medulla in hypertensive patients.
Bomanji J; Flatman WD; Horne T; Fettich J; Britton KE; Ross G; Besser GM
J Nucl Med; 1987 Mar; 28(3):319-24. PubMed ID: 3819850
[TBL] [Abstract][Full Text] [Related]
23. Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.
Nakajo M; Shapiro B; Glowniak J; Sisson JC; Beierwaltes WH
J Nucl Med; 1983 Dec; 24(12):1127-34. PubMed ID: 6644373
[TBL] [Abstract][Full Text] [Related]
24. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.
Shapiro B; Copp JE; Sisson JC; Eyre PL; Wallis J; Beierwaltes WH
J Nucl Med; 1985 Jun; 26(6):576-85. PubMed ID: 2860214
[TBL] [Abstract][Full Text] [Related]
25. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
26. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.
Gelfand MJ; Elgazzar AH; Kriss VM; Masters PR; Golsch GJ
J Nucl Med; 1994 Nov; 35(11):1753-7. PubMed ID: 7965151
[TBL] [Abstract][Full Text] [Related]
27. [Gammagraphy with 123I-meta-iodobenzylguanidine in the diagnosis of pheochromocytoma].
Caballero O; Ferris J; Escobedo JM; Pérez A
Med Clin (Barc); 1989 Apr; 92(14):526-9. PubMed ID: 2755223
[TBL] [Abstract][Full Text] [Related]
28. Iodine-131 MIBG for locating pheochromocytoma.
Schober O; Gratz KF; Hundeshagen H
J Nucl Med; 1986 Jul; 27(7):1222-3. PubMed ID: 3723197
[No Abstract] [Full Text] [Related]
29. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M
Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
[TBL] [Abstract][Full Text] [Related]
30. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
[TBL] [Abstract][Full Text] [Related]
31. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Khafagi FA; Shapiro B; Fig LM; Mallette S; Sisson JC
J Nucl Med; 1989 Apr; 30(4):481-9. PubMed ID: 2738677
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
[TBL] [Abstract][Full Text] [Related]
33. Strong uptake of 111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma.
Manil L; Perdereau B; Barbaroux C; Brixy F
Int J Cancer; 1994 Apr; 57(2):245-6. PubMed ID: 7908895
[TBL] [Abstract][Full Text] [Related]
34. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.
Shulkin BL; Koeppe RA; Francis IR; Deeb GM; Lloyd RV; Thompson NW
Radiology; 1993 Mar; 186(3):711-5. PubMed ID: 8430179
[TBL] [Abstract][Full Text] [Related]
35. Neural crest tumors: I-123 MIBG imaging in children.
Paltiel HJ; Gelfand MJ; Elgazzar AH; Washburn LC; Harris RE; Masters PR; Golsch GJ
Radiology; 1994 Jan; 190(1):117-21. PubMed ID: 8259387
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
37. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
Nakajo M; Shapiro B; Copp J; Kalff V; Gross MD; Sisson JC; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
[TBL] [Abstract][Full Text] [Related]
38. [Gammagraphic localization of pheochromocytoma using 131I-meta-iodobenzoylguanidine (131I-MIBG)].
Bellido CA; Barontini MB; Haessler A; Mazzei CM; Schere DB; Mosso HE
Rev Clin Esp; 1985 Jun; 177(1):45. PubMed ID: 4035040
[No Abstract] [Full Text] [Related]
39. Menadione inhibits MIBG uptake in two neuroendocrine cell lines.
Cornelissen J; Tytgat GA; van den Brug M; van Kuilenburg AB; Voûte PA; van Gennip AH
J Neurooncol; 1997 Jan; 31(1-2):147-51. PubMed ID: 9049842
[TBL] [Abstract][Full Text] [Related]
40. Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication.
Lynn MD; Shapiro B; Sisson JC; Swanson DP; Mangner TJ; Wieland DM; Meyers LJ; Glowniak JV; Beierwaltes WH
J Nucl Med; 1984 Apr; 25(4):436-40. PubMed ID: 6544815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
